These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38155377)

  • 1. MicroRNA profiling in complete and partial hydatidiform moles.
    Chia WK; Yeoh HXY; Mustangin M; Khong TY; Wong YP; Tan GC
    Malays J Pathol; 2023 Dec; 45(3):353-362. PubMed ID: 38155377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression.
    Lin LH; Maestá I; St Laurent JD; Hasselblatt KT; Horowitz NS; Goldstein DP; Quade BJ; Sun SY; Braga A; Fisher RA; Berkowitz RS; Elias KM
    Am J Obstet Gynecol; 2021 Apr; 224(4):372.e1-372.e30. PubMed ID: 33031755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA Expression Profiling in Hydatidiform Mole for the Prediction of Postmolar GTN : MicroRNA Profile in Postmolar GTN.
    Teerapakpinyo C; Areeruk W; Tantbirojn P; Phupong V; Shuangshoti S; Lertkhachonsuk R
    Technol Cancer Res Treat; 2022; 21():15330338211067309. PubMed ID: 35023789
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of microRNA signature in the progression of gestational trophoblastic disease.
    Zhao JR; Cheng WW; Wang YX; Cai M; Wu WB; Zhang HJ
    Cell Death Dis; 2018 Jan; 9(2):94. PubMed ID: 29367697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of maspin in gestational trophoblastic disease.
    Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
    Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of recurrent molar pregnancies following complete and partial hydatidiform moles.
    Eagles N; Sebire NJ; Short D; Savage PM; Seckl MJ; Fisher RA
    Hum Reprod; 2015 Sep; 30(9):2055-63. PubMed ID: 26202916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-30a-5p inhibits proliferation and metastasis of hydatidiform mole by regulating B3GNT5 through ERK/AKT pathways.
    Guo Z; Sun Q; Liao Y; Liu C; Zhao W; Li X; Liu H; Dong M; Shang Y; Sui L; Kong Y
    J Cell Mol Med; 2020 Aug; 24(15):8350-8362. PubMed ID: 32575164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered p16 and Bcl-2 expression reflects pathologic development in hydatidiform moles and choriocarcinoma.
    Candelier JJ; Frappart L; Yadaden T; Poaty H; Picard JY; Prévot S; Coullin P
    Pathol Oncol Res; 2013 Apr; 19(2):217-27. PubMed ID: 23065465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of gestational trophoblastic disease by genotyping and chromosome in situ hybridization.
    Lai CY; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Tsao SW; Cheung AN
    Mod Pathol; 2004 Jan; 17(1):40-8. PubMed ID: 14631372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric and clinicopathologic study of 197 hydatidiform moles with special reference to the significance of cytometric aneuploidy and literature review.
    Fukunaga M; Endo Y; Ushigome S
    Cytometry; 1995 Jun; 22(2):135-8. PubMed ID: 7587744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Underexpression of 4 placenta-associated microRNAs in complete hydatidiform moles.
    Na Q; Wang D; Song W
    Int J Gynecol Cancer; 2012 Jul; 22(6):1075-80. PubMed ID: 22672989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in gene expression profiles of hydatidiform mole and choriocarcinoma as compared with trophoblast hyperplasia].
    Cui JQ; Shi YF; Zhou HJ; Li JQ
    Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):727-31. PubMed ID: 15733390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-21 Is Overexpressed in Hydatidiform Mole Tissues and Promotes Proliferation, Migration, and Invasion in Choriocarcinoma Cells.
    Wang YX; Zhao JR; Xu YY; Wu WB; Zhang HJ
    Int J Gynecol Cancer; 2017 Feb; 27(2):364-374. PubMed ID: 27922982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy.
    Sebire NJ; Fisher RA; Foskett M; Rees H; Seckl MJ; Newlands ES
    BJOG; 2003 Jan; 110(1):22-6. PubMed ID: 12504931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma.
    Fulop V; Mok SC; Genest DR; Szigetvari I; Cseh I; Berkowitz RS
    J Reprod Med; 1998 Feb; 43(2):101-10. PubMed ID: 9513871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression patterns of ERVWE1/Syncytin-1 and other placentally expressed human endogenous retroviruses along the malignant transformation process of hydatidiform moles.
    Bolze PA; Patrier S; Cheynet V; Oriol G; Massardier J; Hajri T; Guillotte M; Bossus M; Sanlaville D; Golfier F; Mallet F
    Placenta; 2016 Mar; 39():116-24. PubMed ID: 26992684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease.
    Zheng XZ; Qin XY; Chen SW; Wang P; Zhan Y; Zhong PP; Buza N; Jin YL; Wu BQ; Hui P
    Mod Pathol; 2020 Oct; 33(10):1979-1988. PubMed ID: 32404958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53, p21, Rb and mdm2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma.
    Fulop V; Mok SC; Genest DR; Gati I; Doszpod J; Berkowitz RS
    J Reprod Med; 1998 Feb; 43(2):119-27. PubMed ID: 9513873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptomic and immunohistochemical approaches identify HLA-G as a predictive biomarker of gestational choriocarcinoma resistance to monochemotherapy.
    Bolze PA; Lopez J; Allias F; Hajri T; Patrier S; Devouassoux-Shisheboran M; Massardier J; You B; Golfier F; Mallet F
    Gynecol Oncol; 2020 Sep; 158(3):785-793. PubMed ID: 32513563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
    Niemann I; Hansen ES; Sunde L
    Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.